SlideShare a Scribd company logo
1 of 127
Download to read offline
Red and white lesions of the
oral mucosa
.Hereditary white lesions
 Leukodema
 White sponge nevus
 Hereditary benign intraepithelial
dyskeratosis
 Darrier’s disease
Reactive/inflammatory white
lesions






Frictional (Traumatic) keratosis
Chemical injuries of the oral mucosa
Actinic keratosis (cheilitis)
Smokeless tobacco-induced keratosis
Nicotine stomatitis
Infectious white lesions and white
:and red lesions




Oral hairy leukoplakia
Candidiasis
Mucous patches
Idiopathic "TRUE" leukoplakia
Erythroplakia
 Oral lichen planus
 Lichenoid reactions
Lupus erythematosus (systemic
)and discoid
:Miscellaneous lesions
 Oral submucous fibrosis.
 Skin graft.
:Hereditary White Lesions
 Leukoedema:
Leukoedema is a common mucosal
alteration that represents a variation of the
normal condition rather than a true
pathologic change.
: Features
 Faint, white, diffuse, and filmy appearance
 Numerous surface folds resulting in wrinkling
of the mucosa.
 It cannot be scraped off
 It disappears or fades upon stretching
the mucosa.
 Microscopic examination reveals thickening
of the epithelium, with significant intracellular
edema of the stratum spinosum. The
surface of the epithelium may demonstrate a
thickened layer of parakeratin.
Leukoedema
Treatment
 No treatment is indicated, no malignant
change has been reported.
:White Sponge Nevus
 The disease usually involves the oral
mucosa and (less frequently) the mucous
membranes of the nose, esophagus,
genitalia, and rectum.
 The lesions may be present at birth or may
first manifest or become more intense at
puberty.
:Features
 Bilateral symmetric white, soft, “spongy”, or velvety
thick plaques of the buccal mucosa.
 Other sites in the oral cavity may be involved,
including the ventral surface of the tongue, floor of
the mouth, labial mucosa, soft palate, and alveolar
mucosa.
 Asymptomatic and does not exhibit tendencies
toward malignant change.
 Histopathologic features are epithelial thickening,
parakeratosis, a peculiar perinuclear condensation
of the cytoplasm, and vacuolization of the
suprabasal layer of keratinocytes
:White Sponge Nevus
:Treatment
 No treatment is indicated for this benign and
asymptomatic condition.
Hereditary Benign Intraepithelial
:Dyskeratosis
1- Oral Lesions:
 Thick, corrugated, asymptomatic, white
“spongy” plaques involving the buccal and
labial mucosa.
 Other intraoral sites include the floor of the
mouth, the lateral tongue, the gingiva, and
the palate.
 Detected in the first year of life and gradually
increase in intensity until the teens.
White lesions ppt
2- Eye Lesions
 Thick, gelatinous, foamy, and opaque
plaques form adjacent to the cornea.
 The plaques may exhibit seasonal
prominence, with many patients reporting
more-pronounced lesions in the Spring and
regression during the Summer months.
 Blindness due to corneal vascularization
may occur.
Histopathologic Features:
 Epithelium exhibits marked parakeratin
production with thickening of the stratum
spinosum and the presence of numerous
dyskeratotic cells (eosinophilic cells that
resemble epithelial pearls).
 Treatment:
 No treatment is required for the oral lesions.
For evaluation and treatment of the ocular
lesions, the patient should be referred to an
ophthalmologist.
Darrier’s Disease: (Keratosis
(Follicularis
 A genetic disorder characterized by a
persistent eruption of hyperkeratotic
papules.
:Pathology
 Fissures (lacunae) appear due to acantholysis
above the basal layer. They later extend
irregularly.
 Small groups of cells around the lacunae become
separated from their neighbours, enlarge and
present a darkly staining nucleus surrounded by
clear cytoplasm and a glistening ring simulating a
membrane. These corps ronds are cells showing
premature partial keratinization (dyskeratosis);
they give rise to the grains, small cells with
shrunken cytoplasm, seen in the upper layers of
the epidermis.
 Skin Lesions:
A firm, rather greasy, harsh papule, which
is skin coloured, yellow-brown or brown.
Coalescence of the papules produces
irregular warty plaques or papillomatous
masses, which in the flexures, become
vegetating and malodorous.
 Oral Lesions:
White umbilicate or cobblestone papules
on the palate, tongue, buccal mucosa,
epiglottis, pharyngeal wall, vulva,
oesophagus or rectum may occur, as may
hypertrophy of gums.
Confluence of the papules may form patches
simulating leukoplakia. Blockage of the
salivary glands may be associated
Nail Lesions:
Characteristic nail changes are seen:
 Broad, white, longitudinal bands;
 Broad, slightly translucent, red, longitudinal
bands;
 A sandwich of red and white longitudinal
bands, often with a V-shaped nick at the
free margin of the nail.
:Ear Lesions

 The external auditory meatus may be
blocked by accumulated keratotic debris
Reactive and Inflammatory White
Lesions:
Frictional Keratosis
:Cheek Chewing
Chemical Injuries of the Oral
:Mucosa
White lesions ppt
(:Actinic Keratosis (Cheilitis
Smokeless Tobacco-lnduced
:Keratosis
:Nicotine Stomatitis
White lesions ppt
White lesions ppt
White lesions ppt
White lesions ppt
Infectious White Lesions and
White and Red Lesions
Oral Hairy Leukoplakia:
 Corrugated white lesion
 Usually occurs on the
lateral or ventral
surfaces of the tongue
 In patients with severe
immunodeficiency. The
most common disease
associated with oral
hairy leukoplakia is HIV
infection.
 Epstein-Barr virus (EBV(
is the causative agent
:Histopathology
 Hyperparakeratosis with an irregular surface,
 Acanthosis with superficial edema,
 Koilocytic cells (virally affected "balloon" cells) in
the spinous layer. The characteristic microscopic
feature is the presence of homogeneous viral
nuclear inclusions with a residual rim of normal
chromatin.
 Demonstrating the presence of EBV through in
situ hybridization, electron microscopy, or
polymerase chain reaction
:Treatment and Prognosis
 The condition usually disappears when
antiviral medications such as zidovudine, or
acyclovir are used in the treatment of the
HIV infection .
Oral Candidosis
 Because Candida are normal oral
inhabitants, thrush and other forms of oral
candidiasis may be classified as specific
endogenous infections.
Important predisposing factors for
oral candidosis
– Immunodeficiency (e.g. diabetes mellitus or AIDS) or
immunosuppression (including steroid inhalers, cancer
chemotherapy, and radiotherapy).
– Poor oral hygiene
– Pregnancy
– Anaemia
– Suppression of the normal oral flora by antibacterial
drugs
– Xerostomia
– Haematologic malignancies
:Spectrum of oral candidosis
Acute candidosis
 Thrush (acute pseudomembranous candidosis).
 Acute antibiotic stomatitis (acute atrophic or erythematous)
Chronic candidosis
 Denture-induced stomatitis
 Chronic hyperplastic candidosis (candidal leukoplakia)
 Median rhomboid glossitis
 Chronic mucocutaneous candidosis
 Erythematous candidosis
Angular stomatitis (common to all types of oral candidosis).
Acute Pseudomembranous
(Candidosis (Thrush
Clinical Features:
 Painless, soft, friable, and creamy plaques on the
mucosa.
 Can be easily wiped off, to expose an
erythematous mucosa or shallow ulceration.
 Their extent varies from isolated small flecks to
widespread confluent plaques.
 Angular stomatitis is frequently associated as it is
with any form of intra-oral candidosis.
 Sometimes a prodrome of bad taste or loss of taste
sensation precedes the appearance of the lesions.
White lesions ppt
Pathology
 A Gram-stained smear shows large masses of
tangled hyphae, detached epithelial cells and
leucocytes.
 Biopsy shows hyperplastic epithelium infiltrated by
inflammatory oedema and cells, predominantly
neutrophils.
 Staining with PAS shows many candidal hyphae
growing down through the epithelial cells to the
junction of the plaque with the spinous cell layer.
Management
 Control of any local cause such as topical
antibiotic treatment .
 Nystatin or amphotericin lozenges (topical
antifungals) should allow the oral microflora
to return to normal.
 Failure of response to topical antifungals
suggests immune deficiency.
 In immunodeficient patients as in HIV
infection, candidosis may respond to
fluoconazole or itraconazole.
:Acute Antibiotic Stomatitis
 Overuse or topical oral use of antibiotics,
especially tetracycline, suppressing normal
competing oral flora.
 Clinically, the whole mucosa is red and
sore. Flecks of thrush may be present.
 Resolution may follow withdrawal of the
antibiotic but is accelerated by topical
antifungal treatment.
 Generalized candidal erythema which is
clinically similar, can also be a consequence
of xerostomia which promotes candidal
infection.
 It is a typical complication of Sjogren's
syndrome.
 Nystatin suspension or miconazole gel held
in the mouth is usually effective.
:Denture-induced Stomatitis
 Asymptomatic erythema sharply limited to
the area of mucosa occluded by a wellfitting upper denture or even an orthodontic
plate.
 Similar inflammation is not seen under the
more mobile lower denture which allows a
relatively free flow of saliva beneath it.
 Angular stomatitis is frequently associated
and may form the chief complaint.
White lesions ppt
:Pathology
 Gram-stained smears show candidal hyphae and
some yeast forms which have proliferated in the
interface between denture base and mucosa.


Histologically, there is typically mild acanthosis
with prominent blood vessels superficially and a
mild
chronic
inflammatory
infiltrate.
The
inflammation is probably a response to enzymes
such as phospholipases produced by the fungus
:Treatment
 Denture cleansing .Cleansers can be divided into groups according to
their primary components: alkaline peroxides, hypochlorites, acids,
disinfectants, and enzymes .Yeast lytic enzymes and proteolytic
enzymes are the most effective against the infection.
 Denture soak solution containing benzoic acid completely eradicates C
albicans from the denture surface as it is taken up into the acrylic resin
and eliminates the organism from the internal surface of the prosthesis.
 A protease-containing denture soak also effectively removes denture
plaque, especially when combined with brushing.
 An oral rinse containing 0.12% chlorhexidine gluconate results in
complete elimination of the presence of C albicans on the acrylic resin
surface of the denture and in reduction of palatal inflammation .
 Diet: High-sucrose diets should be avoided.
. Median Rhomboid Glossitis
 Erythematous patches
of atrophic papillae
located in the central
area of the dorsum of
the
tongue
are
considered a form of
chronic
atrophic
candidiasis.
:Chronic Hyperplastic Candidiasis
 Candidal leukoplakia is considered a chronic form
of oral candidiasis in which firm white leathery
plaques are detected on the cheeks, lips, palate,
and tongue.
 Mycelial invasion of the deeper layers of the
mucosa and skin occurs, causing a prolifertive
response of host tissue.
 The differentiation of candidal leukoplakia from
other forms of leukoplakia is based on finding
periodic acid-Schiff (PAS)-positive hyphae in
leukoplakic lesions.
Chronic Mucocutaneous
:Candidiasis
 Persistent infection with Candida usually
occurs as a result of a defect in cellmediated immunity or may be associated
with iron deficiency. Hyperplastic
mucocutaneous lesions, localized
granulomas, and adherent white plaques on
affected mucous membranes are the
prominent lesions that identify chronic
mucocutaneous candidiasis (CMC).
White lesions ppt
White lesions ppt
White lesions ppt
Two categories of CMC have been
described:
(1( Syndrome-associated CMC (further
categorized as either familial or chronic).
(2( Localized and diffuse CMC.
Candidiasis endocrinopathy
)syndrome (CES
 A rare autosomal recessive disorder
characterized by an onset of CMC during
infancy or early childhood, associated with
the appearance of hypoparathyroidism,
hypoadrenocorticism and other endocrine
anomalies
 Patients develop persistent oral candidiasis
and hyperplastic infections of the nail folds
at an early age.
Chronic candidiasis associated with
thymoma
 The other syndrome-associated form ,
which appears with other autoimmune
abnormalities such as myasthenia gravis.
Localized and diffuse CMC
 Localized CMC is a variant associated with
chronic oral candidiasis and lesions of the
skin and nails.
 The diffuse variant is characterized by
randomly occurring cases of severe
mucocutaneous candidiasis with
widespread skin involvement and
development of Candida granulomas.
Management
Both oral and cutaneous lesions of CMC
can be controlled by the continuous use of
systemic antifungal drugs.
Once treatment is discontinued, the
lesions rapidly reappear.
:Erythematous Candidosis
 This term applies to red mucosal macules
due to Candida albicans infection in HIV –
positive patients. Favoured sites, in order of
frequency, are the hard palate, dorsum of
the tongue and soft palate. Treatment with
intraconazole is usually effective.
:Angular Stomatitis
 Angular stomatitis is typically caused by
leakage of Candida- infected saliva at the
angles of the mouth. It can be seen in
infantile thrush ,in denture wearers or in
association with chronic hyperplastic
candidosis. It is a characteristic sign of
candidal infection.
White lesions ppt
:Treatment of Oral Candidiasis
Treatment of underlying predisposing factors
(if possible)
Antifungal Drugs





Antifungal antibiotics nystatin and amphotericin B.
Imidazole derivatives (clotrimazole, miconazole) are
available for topical use (cream, oral gel).
Systemic therapy includes the use of any one of these
three: ketoconazole, itraconazole, and fluconazole.
Fluconazole and amphotericin B may be used
intravenously for the treatment of the resistant lesions
of CMC and systemic candidiasis.
 Patients for whom predisposing factors such
as xerostomia and immunodeficiency
cannot be eliminated may need either
continuous or repeated treatment to prevent
recurrences.
 The consumption of yogurt two to three
times per week and improved oral hygiene
can also help.
:Idiopathic “TRUE” Leukoplakia
 Leukoplakia is a white oral precancerous
lesion with a recognizable risk for malignant
transformation.
 Leukoplakia is currently defined as “a white
patch or plaque that cannot be
characterized clinically or pathologically as
any other disease”.
Etiology
 A number of locally acting etiologic agents,
including
tobacco,
alcohol,
candidiasis,
electrogalvanic
reactions,
sunlight
and
(possibly) herpes simplex and papilloma
viruses, have been implicated as causative
factors for leukoplakia.
 Alcohol consumption alone is not associated
with an increased risk of developing leukoplakia,
but alcohol is thought to serve as a promoter that
exhibits a strong synergistic effect with tobacco.
:Clinical Features
More frequently found in men
Can occur on any mucosal surface
Infrequently causes discomfort or pain.
Causes change in physical characteristics of
tissues.
 Prevalence increases rapidly with age.
 Approximately 70% of oral leukoplakia lesions are
found on the buccal mucosa, vermilion border of
the lower lip, and gingiva.
 Lesions of the tongue and the floor of the mouth
account for more than 90% of cases that show
dysplasia or carcinoma.




Subtypes
 Homogeneous
leukoplakia
welldefined white patch,
that is slightly elevated
and
that
has
a
fissured, wrinkled, or
corrugated
surface.
On palpation, these
lesions
may
feel
leathery to “dry, or
cracked mud-like”.
 Nodular
(speckled)
leukoplakia
the
name
refers to a mixed red-and–
white lesion in which
keratotic white nodules or
patches are distributed over
an atrophic erythematous
background. This type of
leukoplakia is associated
with a higher malignant
transformation rate.
Nodular (speckled) leukoplakia
Verrucous leukoplakia
 Thick white lesions with
papillary surfaces .
 Usually heavily keratinized
 Most often seen in older
adults in the sixth to eighth
decades of life.
 Some of these lesions may
exhibit
an
exophytic
growth pattern.
Proliferative verrucous leukoplakia
Extensive papillary or verrucoid white
plaques that tend to slowly involve multiple
mucosal sites in the oral cavity and to
transform into squamous cell carcinomas
over a period of many years.
:Histopathologic Features
 Parakeratosis or orthokeratosis or both, alternately.
 The epithelium ranges from thinner than normal
(atrophic) to much thicker (acanthotic)
 Most leukoplakias show no dysplastic changes
 A minority display a range of dysplasia from mild to
severe and treatment is planned partly on this
basis.
 An inflammatory reaction of lymphocytes and
plasma cells is often present in the underlying
connective tissue.
:Diagnosis and Management
 If
a
leukoplakia
lesion
disappears
spontaneously or through the elimination of
an irritant, no further testing is indicated.
 For the persistent lesion, the definitive
diagnosis is established by tissue biopsy.
 Adjunctive methods as vital staining with
toluidine blue and cytobrush are helpful in
selecting the most appropriate spot for
biopsy .
 Toluidine blue staining uses a 1% aqueous
solution of the dye which stains dysplastic
and malignant cells and resists washing
away by rinsing with 1% acetic acid .
 Cytobrush technique utilizes a brush with
firm bristles that obtains individual cells from
the full thickness of epithelium for cytologic
examination .
 Definitive treatment involves surgical
excision although cryosurgery and laser
ablation are often preferred because of their
precision and rapid healing.
:Prognosis
 Clinical signs of malignant transformation of
leukoplakia include :
Ulceration , erythroplasia , bleeding ,
induration and lymphadenopathy
 After surgical removal long-term monitoring
of the lesion site is important since
recurrences are frequent and because
additional leukoplakias may develop.
Erythroplakia
 “Bright
red
velvety
plaque or patch which
cannot be characterized
clinically or histopathologically as being
due
to
any
other
condition”.
Erythroplakia
:Clinical Features
 Erythroplakia occurs predominantly in older
men, in the sixth and seventh decades of
life.
 Erythroplakias are more commonly seen on
the floor of the mouth, the ventral tongue,
the soft palate, and the tonsillar fauces, all
prime areas for the development of
carcinoma. Multiple lesions may be present.
 Almost all of the lesions are asymptomatic.
:Histopathologic Features
 80 to 90% of cases of erythroplakia are
histopathologically
severe
epithelial
dysplasia, carcinoma in situ, or invasive
carcinoma.
:Differential Diagnosis
 In view of the clinical significance of
erythroplakia, its differentiation from
other red inflammatory lesions of the oral
mucosa is critical.
 Clinically similar lesions may include
erythematous candidiasis, areas of
mechanical irritation, denture stomatitis,
vascular lesions, and a variety of
nonspecific inflammatory lesions
:Lichen Planus
 Lichen planus is a common chronic
inflammatory disease of skin and mucous
membranes. It mainly affects patients of
middle age or over. Oral lesions have
characteristic appearances and distribution
:Aetiology
 The predominantly T-lymphocyte infiltrate
suggests
cell-mediated
immunological
damage to the epithelium
:Clinical Features
Skin Lesions:
 Pruritic, polyangular, planar papules and plaques , 2 to 4
mm in diameter, with angular borders, a violaceous color,
and a distinct sheen in cross-lighting.
 Usually symmetrically distributed most commonly on the
flexor surfaces of the wrists, legs, trunk. The face is rarely
involved during the acute phase.
 New papules may appear at sites of minor skin injury
(Koebner’s phenomenon).
 Lesions may coalesce or change over time becoming
hyperpigmented, atrophic hyperkeratotic (hypertrophic LP)
or vesiculobullous.
 If the scalp is affected,there is patchy scarring alopecia
White lesions ppt
White lesions ppt
Nail Lesions:
 Nails are involved in up to 10% of cases.
Findings vary in intensity with nail bed
discoloration ,longitudinal ridging and lateral
thinning and complete loss of the nail matrix
and nail with scarring of the proximal nail
fold onto the nail bed.
White lesions ppt
:Oral Lesions





The reticular form
Atrophic lichen planus
Erosive lesions
Bullous lesions

 Atrophic or erosive lichen planus involving
the gingivae results in desquamative
gingivitis
White lesions ppt
White lesions ppt
:Histopathologic Features
 Three features are considered essential for the
histopathologic diagnosis of lichen planus:
 (1) Areas of hyperparakeratosis or
hyperorthokeratosis.
 (2) “liquefaction degeneration” or necrosis of the
basal cell layer which is often replaced by an
eosinophilic band.
 (3) A dense subepithelial band of lymphocytes.
This linear sub-basilar lymphocytic infiltration is
composed largely of T cells
White lesions ppt
 Isolated epithelial cells, shrunken with
eosinophilic cytoplasm and one or more
pyknotic nuclear fragments (Civatte bodies),
are often scattered within the epithelium and
superficial lamina propria. These represent
cells that have undergone apoptosis.
:Treatment
 Asymptomatic lesions require no treatment.
 Topical high-potency corticosteroids, as pastes or as gels.
 Erosive lesions may respond to oral dapsone or
cyclosporine rinses.
 Systemic steroids : Prednisone tablets with dosages
varying between 40 and 80 mg daily
 Intralesional injection of corticosteroid may be used in
lesions resistant to topical and systemic therapy
triamcinolone acetonide ampules are used (weekly
regimen).
 Systemically administered dapsone, hydroxychloroquine,
azathioprine and cyclosporine may help in cases resistant
to corticosteroids
 Drug combinations could also be used.
Lichenoid Reactions
 This term is given to lichen planus-like lesions
caused by either systemic drug treatment or those
where the histological picture is not completely
diagnostic.
 Oral lichenoid reactions are most frequently
responses to restorative materials, either amalgam
or polymeric. Lesions are localized to mucosa in
contact, not just close to, restorations.
 Lichenoid reactions are treated in exactly the
same way as lichen planus with withdrawal of
drug(s) if possible or removal of restoration.
:Lupus Erythematosus
 Lupus erythematosus is an autoimmune
connective tissue disease which has two
main forms namely systemic and discoid.
Either can give rise to oral lesions which
may appear similar to those of oral lichen
planus
Systemic Lupus Erythematosus
 Has varied effects. Any organ system can be affected. A
great variety of autoantibodies, particularly antinuclear, is
produced.
Pathological features of systemic lupus erythematosus:
Macroscopic:
 Pleurisy.
 Pericarditis.
 Libman-sacks endocarditis.
 Lymphadenopathy.
 Splenomegaly.
 May be none.
White lesions ppt
Microscopic:
 Immunoglobulins and complement at the
dermo-epidermal junction in skin lesions
(90%) and uninvolved skin (60%).
 Haematoxylin bodies in the endocardium,
renal glomeruli and elsewhere.
 Periarterial fibrosis of the spleen.
 Wire loop lesions in the kidneys.
immunoglobulin & complement
deposits at basement membrane
:zone & nuclei of epithelial cells
:Discoid Lupus
 A skin disease with mucocutaneous lesions
indistinguishable clinically from those of
systemic lupus. These may be associated
with arthralgias but rarely, significant
autoantibody production
Clinical Features:
:A) Skin Lesions
Cutaneous features of systemic lupus erythematosus.
 Butterfly rash.
 Facial oedema.
 Subacute cutaneous LE.
 Chronic discoid LE.
 Scarring DLE alopecia
 Non-scarring alopecia
 Photosensitivity
 Raynaud’s phenomenon
 Chronic urticaria
 Cutaneous vasculitis
White lesions ppt
White lesions ppt
White lesions ppt
White lesions ppt
:Histopathologic Features
 Liquefaction degeneration of basal cell layer.
 Degenerative changes in the connective tissue
(hyalinization, oedema,..).
 Lupus erythematosus shows more irregular
patterns of acanthosis and lacks the band-like
distribution of lymphocytes in the papillary corium
of lichen planus.
 The inflammatory infiltrate may have a
perivascular distribution.
: Management
 Oral lesions of discoid lupus erythematosus
may respond in some degree to topical
corticosteroids.
 Oral lesions in acute systemic lupus
erythematosus may not respond to doses of
corticosteroids adequate to control systemic
effects of the disease. Under such
circumstances, palliative treatment is
needed until disease activity decreases.
Miscellaneous Lesions:
Oral Submucous Fibrosis
 A slowly progressive chronic fibrotic disease
of the oral cavity and oropharynx,
characterized by fibroelastic change and
inflammation of the mucosa, leading to a
progressive inability to open the mouth,
swallow, or speak.
 These reactions may be the result of either direct
stimulation from exogenous antigens like Areca
alkaloids or changes in tissue antigenicity that may
lead to an autoimmune response.
 It occurs almost exclusively in the Indian
subcontinent.
 The inflammatory response releases cytokines and
growth factorsthat promote fibrosis by inducing the
proliferation of fibroblasts, up-regulating collagen
synthesis and down-regulating collagenase
production.
:Etiology
 General nutritional and vitamin deficiencies
and hypersensitivity to certain dietary
constituents such as chili peppers, chewing
tobacco, habitual use of betel and its
constituents (Areca catechu).
:Clinical Features
 The disease first presents with a burning sensation
of the mouth, particularly during consumption of
spicy foods.
 Often accompanied by the formation of vesicles or
ulcerations and by excessive salivation or
xerostomia and altered taste sensations.
 Gradually, patients develop a stiffening of the
mucosa, with a dramatic reduction in mouth opening
and with difficulty in swallowing and speaking.
 The mucosa appears blanched and opaque with the
appearance of fibrotic bands that can easily be
palpated.
 Usually involves the buccal mucosa, soft palate,
posterior pharynx, lips, and tongue.
White lesions ppt
White lesions ppt
:Histologic Features
 Severely atrophic epithelium with complete
loss of rete ridges.
 Varying degrees of epithelial atypia may be
present.
 The underlying lamina propria exhibits
severe hyalinization, with homogenization of
collagen. Cellular elements and blood
vessels are greatly reduced.
:Treatment and Prognosis
 Oral submucous fibrosis is regarded as a
premalignant condition.
 Oral submucous fibrosis is very resistant to
treatment.
 Submucosal injected steroids and hyaluronidase,
are some of the agents that have been used.
 In severe cases surgical intervention is the only
treatment but the fibrous bands and other symptoms
often recur within a few months to a few years.
:Skin Grafts
 A skin graft may be placed in the mouth to cover a
raw area left after excision of a lesion.
 Skin grafts typically appear sharply demarcated
smooth and paler than the surrounding mucosa
and occasionally contain hairs . Grafts on the
dorsum of the tongue may become corrugated and
less easy to differentiate from leukoplakia.
White lesions ppt

More Related Content

What's hot

What's hot (20)

White Lesions of Oral Cavity - M. Abdelhamid
White Lesions of Oral Cavity - M. AbdelhamidWhite Lesions of Oral Cavity - M. Abdelhamid
White Lesions of Oral Cavity - M. Abdelhamid
 
Pyogenic Granuloma
Pyogenic GranulomaPyogenic Granuloma
Pyogenic Granuloma
 
White Lesions
White LesionsWhite Lesions
White Lesions
 
Oral Lichen Planus
Oral Lichen PlanusOral Lichen Planus
Oral Lichen Planus
 
Oral Submucous Fibrosis
Oral Submucous FibrosisOral Submucous Fibrosis
Oral Submucous Fibrosis
 
Adenomatoid odontogenic tumor
Adenomatoid odontogenic tumorAdenomatoid odontogenic tumor
Adenomatoid odontogenic tumor
 
Reactive white lesions oral pathology
Reactive white lesions oral pathologyReactive white lesions oral pathology
Reactive white lesions oral pathology
 
Oral White lesions
Oral White lesionsOral White lesions
Oral White lesions
 
Adenomatoid odontogenic tumour and others
Adenomatoid odontogenic tumour and othersAdenomatoid odontogenic tumour and others
Adenomatoid odontogenic tumour and others
 
Red and White Lesions of the.pptx
Red and White Lesions of the.pptxRed and White Lesions of the.pptx
Red and White Lesions of the.pptx
 
Allergic and Immunologic Diseases of Oral Cavity
Allergic and Immunologic Diseases of Oral CavityAllergic and Immunologic Diseases of Oral Cavity
Allergic and Immunologic Diseases of Oral Cavity
 
Pyogenic granuloma a case presentation
Pyogenic granuloma a case presentationPyogenic granuloma a case presentation
Pyogenic granuloma a case presentation
 
BENIGN TUMORS OF EPITHELIAL ORIGIN
BENIGN TUMORS OF EPITHELIAL ORIGINBENIGN TUMORS OF EPITHELIAL ORIGIN
BENIGN TUMORS OF EPITHELIAL ORIGIN
 
Odontogenic cysts
Odontogenic  cystsOdontogenic  cysts
Odontogenic cysts
 
RED LESIONS
RED LESIONSRED LESIONS
RED LESIONS
 
oral lichen planus presentation
oral lichen planus  presentationoral lichen planus  presentation
oral lichen planus presentation
 
Oral white lesion
Oral white lesionOral white lesion
Oral white lesion
 
ODONTOGENIC CYSTS
ODONTOGENIC CYSTSODONTOGENIC CYSTS
ODONTOGENIC CYSTS
 
Fibroma- benign tumors
Fibroma- benign tumorsFibroma- benign tumors
Fibroma- benign tumors
 
Oral Lichen Planus (OLP)
Oral Lichen Planus (OLP)Oral Lichen Planus (OLP)
Oral Lichen Planus (OLP)
 

Similar to White lesions ppt

Lesions of oral cavity
Lesions of oral cavityLesions of oral cavity
Lesions of oral cavityJoel Mathew
 
A)benign oral & tg,atypical facial pain,burning pain syndrome
A)benign oral & tg,atypical facial pain,burning pain syndromeA)benign oral & tg,atypical facial pain,burning pain syndrome
A)benign oral & tg,atypical facial pain,burning pain syndromeShekhar Krishna Debnath
 
Lesions of oral cavity
Lesions of oral cavityLesions of oral cavity
Lesions of oral cavityAnwaaar
 
Oral candidiosis: A Review
Oral candidiosis: A ReviewOral candidiosis: A Review
Oral candidiosis: A ReviewZiad Abdul Majid
 
oral manifestations of HIV.pptx
oral manifestations of HIV.pptxoral manifestations of HIV.pptx
oral manifestations of HIV.pptxLubna Nazneen
 
ORAL MANIFESTATIONS OF SYSTEMIC DISEASES.pptx
ORAL MANIFESTATIONS OF SYSTEMIC DISEASES.pptxORAL MANIFESTATIONS OF SYSTEMIC DISEASES.pptx
ORAL MANIFESTATIONS OF SYSTEMIC DISEASES.pptxDr.Mohammed Shanil.P
 
03 02-06 benign mucosal-lesions_of_the_oral_cavity1
03 02-06 benign mucosal-lesions_of_the_oral_cavity103 02-06 benign mucosal-lesions_of_the_oral_cavity1
03 02-06 benign mucosal-lesions_of_the_oral_cavity1Ashish Soni
 
03 02-06 benign mucosal-lesions_of_the_oral_cavity1
03 02-06 benign mucosal-lesions_of_the_oral_cavity103 02-06 benign mucosal-lesions_of_the_oral_cavity1
03 02-06 benign mucosal-lesions_of_the_oral_cavity1Ashish Soni
 
Primary oral ulcerative lesions new
Primary oral ulcerative lesions newPrimary oral ulcerative lesions new
Primary oral ulcerative lesions newAhmed Shakora
 
Non keratotic white lesions of the oral cavity
Non keratotic white lesions of the oral cavityNon keratotic white lesions of the oral cavity
Non keratotic white lesions of the oral cavityMammootty Ik
 
Desquamative Gingivitis Diagnosis and Management
Desquamative Gingivitis Diagnosis and ManagementDesquamative Gingivitis Diagnosis and Management
Desquamative Gingivitis Diagnosis and Managementvinoth kumar
 
candidal infection.pptx
candidal infection.pptxcandidal infection.pptx
candidal infection.pptxaliimad10
 
Desquamative gingivitis
Desquamative gingivitis Desquamative gingivitis
Desquamative gingivitis UTPALHALDER4
 

Similar to White lesions ppt (20)

R&w ppt
R&w pptR&w ppt
R&w ppt
 
Lesions of oral cavity
Lesions of oral cavityLesions of oral cavity
Lesions of oral cavity
 
A)benign oral & tg,atypical facial pain,burning pain syndrome
A)benign oral & tg,atypical facial pain,burning pain syndromeA)benign oral & tg,atypical facial pain,burning pain syndrome
A)benign oral & tg,atypical facial pain,burning pain syndrome
 
Lesions of oral cavity
Lesions of oral cavityLesions of oral cavity
Lesions of oral cavity
 
Oral candidiosis: A Review
Oral candidiosis: A ReviewOral candidiosis: A Review
Oral candidiosis: A Review
 
oral manifestations of HIV.pptx
oral manifestations of HIV.pptxoral manifestations of HIV.pptx
oral manifestations of HIV.pptx
 
ORAL MANIFESTATIONS OF SYSTEMIC DISEASES.pptx
ORAL MANIFESTATIONS OF SYSTEMIC DISEASES.pptxORAL MANIFESTATIONS OF SYSTEMIC DISEASES.pptx
ORAL MANIFESTATIONS OF SYSTEMIC DISEASES.pptx
 
03 02-06 benign mucosal-lesions_of_the_oral_cavity1
03 02-06 benign mucosal-lesions_of_the_oral_cavity103 02-06 benign mucosal-lesions_of_the_oral_cavity1
03 02-06 benign mucosal-lesions_of_the_oral_cavity1
 
03 02-06 benign mucosal-lesions_of_the_oral_cavity1
03 02-06 benign mucosal-lesions_of_the_oral_cavity103 02-06 benign mucosal-lesions_of_the_oral_cavity1
03 02-06 benign mucosal-lesions_of_the_oral_cavity1
 
Cheilitis
CheilitisCheilitis
Cheilitis
 
Primary oral ulcerative lesions new
Primary oral ulcerative lesions newPrimary oral ulcerative lesions new
Primary oral ulcerative lesions new
 
White& red lesions
White& red lesionsWhite& red lesions
White& red lesions
 
Non keratotic white lesions of the oral cavity
Non keratotic white lesions of the oral cavityNon keratotic white lesions of the oral cavity
Non keratotic white lesions of the oral cavity
 
Oral mucosal ulceration
Oral mucosal ulcerationOral mucosal ulceration
Oral mucosal ulceration
 
Pigmented lesions of oral mucosa
Pigmented lesions of oral mucosaPigmented lesions of oral mucosa
Pigmented lesions of oral mucosa
 
Desquamative Gingivitis Diagnosis and Management
Desquamative Gingivitis Diagnosis and ManagementDesquamative Gingivitis Diagnosis and Management
Desquamative Gingivitis Diagnosis and Management
 
White lesions
White lesionsWhite lesions
White lesions
 
candidal infection.pptx
candidal infection.pptxcandidal infection.pptx
candidal infection.pptx
 
Oral candidiasis
Oral candidiasis Oral candidiasis
Oral candidiasis
 
Desquamative gingivitis
Desquamative gingivitis Desquamative gingivitis
Desquamative gingivitis
 

More from Anhar Al-gebaly (13)

Pigmentation today
Pigmentation todayPigmentation today
Pigmentation today
 
Oral ulcersppt
Oral ulcerspptOral ulcersppt
Oral ulcersppt
 
Oral ulcers
Oral ulcersOral ulcers
Oral ulcers
 
Oral ulcers(collection)
Oral ulcers(collection)Oral ulcers(collection)
Oral ulcers(collection)
 
White lesions(collection)
White lesions(collection)White lesions(collection)
White lesions(collection)
 
Oral ulcers(collection)
Oral ulcers(collection)Oral ulcers(collection)
Oral ulcers(collection)
 
Behaviour managment
Behaviour managmentBehaviour managment
Behaviour managment
 
Omd 411
Omd 411Omd 411
Omd 411
 
pigmented lesions
pigmented lesionspigmented lesions
pigmented lesions
 
Career planning
Career  planningCareer  planning
Career planning
 
Whit lesions
Whit lesionsWhit lesions
Whit lesions
 
Oral ulcer revision 1
Oral ulcer revision 1Oral ulcer revision 1
Oral ulcer revision 1
 
Oral ulcers
Oral ulcersOral ulcers
Oral ulcers
 

Recently uploaded

power point presentation of Clinical evaluation of strabismus
power point presentation of Clinical evaluation  of strabismuspower point presentation of Clinical evaluation  of strabismus
power point presentation of Clinical evaluation of strabismusChandrasekar Reddy
 
High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)kishan singh tomar
 
Basic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxBasic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxkomalt2001
 
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.aarjukhadka22
 
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptxORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptxNIKITA BHUTE
 
Neurological history taking (2024) .
Neurological  history  taking  (2024)  .Neurological  history  taking  (2024)  .
Neurological history taking (2024) .Mohamed Rizk Khodair
 
"Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio..."Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio...Sujoy Dasgupta
 
pA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologypA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologyDeepakDaniel9
 
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfPAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfDolisha Warbi
 
Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.kishan singh tomar
 
AUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functionsAUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functionsMedicoseAcademics
 
CPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentCPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentsaileshpanda05
 
Using Data Visualization in Public Health Communications
Using Data Visualization in Public Health CommunicationsUsing Data Visualization in Public Health Communications
Using Data Visualization in Public Health Communicationskatiequigley33
 
historyofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusanguhistoryofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusangu Medical University
 
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfSGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfHongBiThi1
 
MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.whalesdesign
 
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdfSGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdfHongBiThi1
 
blood bank management system project report
blood bank management system project reportblood bank management system project report
blood bank management system project reportNARMADAPETROLEUMGAS
 
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...Shubhanshu Gaurav
 

Recently uploaded (20)

power point presentation of Clinical evaluation of strabismus
power point presentation of Clinical evaluation  of strabismuspower point presentation of Clinical evaluation  of strabismus
power point presentation of Clinical evaluation of strabismus
 
High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)
 
Basic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxBasic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptx
 
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
 
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptxORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptx
 
Neurological history taking (2024) .
Neurological  history  taking  (2024)  .Neurological  history  taking  (2024)  .
Neurological history taking (2024) .
 
"Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio..."Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio...
 
pA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologypA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacology
 
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfPAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
 
Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.
 
AUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functionsAUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functions
 
CPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentCPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing student
 
Using Data Visualization in Public Health Communications
Using Data Visualization in Public Health CommunicationsUsing Data Visualization in Public Health Communications
Using Data Visualization in Public Health Communications
 
historyofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusanguhistoryofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusangu
 
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfSGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
 
Rheumatoid arthritis Part 1, case based approach with application of the late...
Rheumatoid arthritis Part 1, case based approach with application of the late...Rheumatoid arthritis Part 1, case based approach with application of the late...
Rheumatoid arthritis Part 1, case based approach with application of the late...
 
MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.
 
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdfSGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdf
 
blood bank management system project report
blood bank management system project reportblood bank management system project report
blood bank management system project report
 
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
 

White lesions ppt

  • 1. Red and white lesions of the oral mucosa
  • 2. .Hereditary white lesions  Leukodema  White sponge nevus  Hereditary benign intraepithelial dyskeratosis  Darrier’s disease
  • 3. Reactive/inflammatory white lesions      Frictional (Traumatic) keratosis Chemical injuries of the oral mucosa Actinic keratosis (cheilitis) Smokeless tobacco-induced keratosis Nicotine stomatitis
  • 4. Infectious white lesions and white :and red lesions    Oral hairy leukoplakia Candidiasis Mucous patches
  • 7.  Oral lichen planus  Lichenoid reactions
  • 9. :Miscellaneous lesions  Oral submucous fibrosis.  Skin graft.
  • 10. :Hereditary White Lesions  Leukoedema: Leukoedema is a common mucosal alteration that represents a variation of the normal condition rather than a true pathologic change.
  • 11. : Features  Faint, white, diffuse, and filmy appearance  Numerous surface folds resulting in wrinkling of the mucosa.  It cannot be scraped off  It disappears or fades upon stretching the mucosa.  Microscopic examination reveals thickening of the epithelium, with significant intracellular edema of the stratum spinosum. The surface of the epithelium may demonstrate a thickened layer of parakeratin.
  • 13. Treatment  No treatment is indicated, no malignant change has been reported.
  • 14. :White Sponge Nevus  The disease usually involves the oral mucosa and (less frequently) the mucous membranes of the nose, esophagus, genitalia, and rectum.  The lesions may be present at birth or may first manifest or become more intense at puberty.
  • 15. :Features  Bilateral symmetric white, soft, “spongy”, or velvety thick plaques of the buccal mucosa.  Other sites in the oral cavity may be involved, including the ventral surface of the tongue, floor of the mouth, labial mucosa, soft palate, and alveolar mucosa.  Asymptomatic and does not exhibit tendencies toward malignant change.  Histopathologic features are epithelial thickening, parakeratosis, a peculiar perinuclear condensation of the cytoplasm, and vacuolization of the suprabasal layer of keratinocytes
  • 17. :Treatment  No treatment is indicated for this benign and asymptomatic condition.
  • 18. Hereditary Benign Intraepithelial :Dyskeratosis 1- Oral Lesions:  Thick, corrugated, asymptomatic, white “spongy” plaques involving the buccal and labial mucosa.  Other intraoral sites include the floor of the mouth, the lateral tongue, the gingiva, and the palate.  Detected in the first year of life and gradually increase in intensity until the teens.
  • 20. 2- Eye Lesions  Thick, gelatinous, foamy, and opaque plaques form adjacent to the cornea.  The plaques may exhibit seasonal prominence, with many patients reporting more-pronounced lesions in the Spring and regression during the Summer months.  Blindness due to corneal vascularization may occur.
  • 21. Histopathologic Features:  Epithelium exhibits marked parakeratin production with thickening of the stratum spinosum and the presence of numerous dyskeratotic cells (eosinophilic cells that resemble epithelial pearls).
  • 22.  Treatment:  No treatment is required for the oral lesions. For evaluation and treatment of the ocular lesions, the patient should be referred to an ophthalmologist.
  • 23. Darrier’s Disease: (Keratosis (Follicularis  A genetic disorder characterized by a persistent eruption of hyperkeratotic papules.
  • 24. :Pathology  Fissures (lacunae) appear due to acantholysis above the basal layer. They later extend irregularly.  Small groups of cells around the lacunae become separated from their neighbours, enlarge and present a darkly staining nucleus surrounded by clear cytoplasm and a glistening ring simulating a membrane. These corps ronds are cells showing premature partial keratinization (dyskeratosis); they give rise to the grains, small cells with shrunken cytoplasm, seen in the upper layers of the epidermis.
  • 25.  Skin Lesions: A firm, rather greasy, harsh papule, which is skin coloured, yellow-brown or brown. Coalescence of the papules produces irregular warty plaques or papillomatous masses, which in the flexures, become vegetating and malodorous.
  • 26.  Oral Lesions: White umbilicate or cobblestone papules on the palate, tongue, buccal mucosa, epiglottis, pharyngeal wall, vulva, oesophagus or rectum may occur, as may hypertrophy of gums. Confluence of the papules may form patches simulating leukoplakia. Blockage of the salivary glands may be associated
  • 27. Nail Lesions: Characteristic nail changes are seen:  Broad, white, longitudinal bands;  Broad, slightly translucent, red, longitudinal bands;  A sandwich of red and white longitudinal bands, often with a V-shaped nick at the free margin of the nail.
  • 28. :Ear Lesions  The external auditory meatus may be blocked by accumulated keratotic debris
  • 29. Reactive and Inflammatory White Lesions: Frictional Keratosis
  • 31. Chemical Injuries of the Oral :Mucosa
  • 40. Infectious White Lesions and White and Red Lesions Oral Hairy Leukoplakia:  Corrugated white lesion  Usually occurs on the lateral or ventral surfaces of the tongue  In patients with severe immunodeficiency. The most common disease associated with oral hairy leukoplakia is HIV infection.  Epstein-Barr virus (EBV( is the causative agent
  • 41. :Histopathology  Hyperparakeratosis with an irregular surface,  Acanthosis with superficial edema,  Koilocytic cells (virally affected "balloon" cells) in the spinous layer. The characteristic microscopic feature is the presence of homogeneous viral nuclear inclusions with a residual rim of normal chromatin.  Demonstrating the presence of EBV through in situ hybridization, electron microscopy, or polymerase chain reaction
  • 42. :Treatment and Prognosis  The condition usually disappears when antiviral medications such as zidovudine, or acyclovir are used in the treatment of the HIV infection .
  • 43. Oral Candidosis  Because Candida are normal oral inhabitants, thrush and other forms of oral candidiasis may be classified as specific endogenous infections.
  • 44. Important predisposing factors for oral candidosis – Immunodeficiency (e.g. diabetes mellitus or AIDS) or immunosuppression (including steroid inhalers, cancer chemotherapy, and radiotherapy). – Poor oral hygiene – Pregnancy – Anaemia – Suppression of the normal oral flora by antibacterial drugs – Xerostomia – Haematologic malignancies
  • 45. :Spectrum of oral candidosis Acute candidosis  Thrush (acute pseudomembranous candidosis).  Acute antibiotic stomatitis (acute atrophic or erythematous) Chronic candidosis  Denture-induced stomatitis  Chronic hyperplastic candidosis (candidal leukoplakia)  Median rhomboid glossitis  Chronic mucocutaneous candidosis  Erythematous candidosis Angular stomatitis (common to all types of oral candidosis).
  • 46. Acute Pseudomembranous (Candidosis (Thrush Clinical Features:  Painless, soft, friable, and creamy plaques on the mucosa.  Can be easily wiped off, to expose an erythematous mucosa or shallow ulceration.  Their extent varies from isolated small flecks to widespread confluent plaques.  Angular stomatitis is frequently associated as it is with any form of intra-oral candidosis.  Sometimes a prodrome of bad taste or loss of taste sensation precedes the appearance of the lesions.
  • 48. Pathology  A Gram-stained smear shows large masses of tangled hyphae, detached epithelial cells and leucocytes.  Biopsy shows hyperplastic epithelium infiltrated by inflammatory oedema and cells, predominantly neutrophils.  Staining with PAS shows many candidal hyphae growing down through the epithelial cells to the junction of the plaque with the spinous cell layer.
  • 49. Management  Control of any local cause such as topical antibiotic treatment .  Nystatin or amphotericin lozenges (topical antifungals) should allow the oral microflora to return to normal.  Failure of response to topical antifungals suggests immune deficiency.  In immunodeficient patients as in HIV infection, candidosis may respond to fluoconazole or itraconazole.
  • 50. :Acute Antibiotic Stomatitis  Overuse or topical oral use of antibiotics, especially tetracycline, suppressing normal competing oral flora.  Clinically, the whole mucosa is red and sore. Flecks of thrush may be present.  Resolution may follow withdrawal of the antibiotic but is accelerated by topical antifungal treatment.
  • 51.  Generalized candidal erythema which is clinically similar, can also be a consequence of xerostomia which promotes candidal infection.  It is a typical complication of Sjogren's syndrome.  Nystatin suspension or miconazole gel held in the mouth is usually effective.
  • 52. :Denture-induced Stomatitis  Asymptomatic erythema sharply limited to the area of mucosa occluded by a wellfitting upper denture or even an orthodontic plate.  Similar inflammation is not seen under the more mobile lower denture which allows a relatively free flow of saliva beneath it.  Angular stomatitis is frequently associated and may form the chief complaint.
  • 54. :Pathology  Gram-stained smears show candidal hyphae and some yeast forms which have proliferated in the interface between denture base and mucosa.  Histologically, there is typically mild acanthosis with prominent blood vessels superficially and a mild chronic inflammatory infiltrate. The inflammation is probably a response to enzymes such as phospholipases produced by the fungus
  • 55. :Treatment  Denture cleansing .Cleansers can be divided into groups according to their primary components: alkaline peroxides, hypochlorites, acids, disinfectants, and enzymes .Yeast lytic enzymes and proteolytic enzymes are the most effective against the infection.  Denture soak solution containing benzoic acid completely eradicates C albicans from the denture surface as it is taken up into the acrylic resin and eliminates the organism from the internal surface of the prosthesis.  A protease-containing denture soak also effectively removes denture plaque, especially when combined with brushing.  An oral rinse containing 0.12% chlorhexidine gluconate results in complete elimination of the presence of C albicans on the acrylic resin surface of the denture and in reduction of palatal inflammation .  Diet: High-sucrose diets should be avoided.
  • 56. . Median Rhomboid Glossitis  Erythematous patches of atrophic papillae located in the central area of the dorsum of the tongue are considered a form of chronic atrophic candidiasis.
  • 57. :Chronic Hyperplastic Candidiasis  Candidal leukoplakia is considered a chronic form of oral candidiasis in which firm white leathery plaques are detected on the cheeks, lips, palate, and tongue.  Mycelial invasion of the deeper layers of the mucosa and skin occurs, causing a prolifertive response of host tissue.  The differentiation of candidal leukoplakia from other forms of leukoplakia is based on finding periodic acid-Schiff (PAS)-positive hyphae in leukoplakic lesions.
  • 58. Chronic Mucocutaneous :Candidiasis  Persistent infection with Candida usually occurs as a result of a defect in cellmediated immunity or may be associated with iron deficiency. Hyperplastic mucocutaneous lesions, localized granulomas, and adherent white plaques on affected mucous membranes are the prominent lesions that identify chronic mucocutaneous candidiasis (CMC).
  • 62. Two categories of CMC have been described: (1( Syndrome-associated CMC (further categorized as either familial or chronic). (2( Localized and diffuse CMC.
  • 63. Candidiasis endocrinopathy )syndrome (CES  A rare autosomal recessive disorder characterized by an onset of CMC during infancy or early childhood, associated with the appearance of hypoparathyroidism, hypoadrenocorticism and other endocrine anomalies  Patients develop persistent oral candidiasis and hyperplastic infections of the nail folds at an early age.
  • 64. Chronic candidiasis associated with thymoma  The other syndrome-associated form , which appears with other autoimmune abnormalities such as myasthenia gravis.
  • 65. Localized and diffuse CMC  Localized CMC is a variant associated with chronic oral candidiasis and lesions of the skin and nails.  The diffuse variant is characterized by randomly occurring cases of severe mucocutaneous candidiasis with widespread skin involvement and development of Candida granulomas.
  • 66. Management Both oral and cutaneous lesions of CMC can be controlled by the continuous use of systemic antifungal drugs. Once treatment is discontinued, the lesions rapidly reappear.
  • 67. :Erythematous Candidosis  This term applies to red mucosal macules due to Candida albicans infection in HIV – positive patients. Favoured sites, in order of frequency, are the hard palate, dorsum of the tongue and soft palate. Treatment with intraconazole is usually effective.
  • 68. :Angular Stomatitis  Angular stomatitis is typically caused by leakage of Candida- infected saliva at the angles of the mouth. It can be seen in infantile thrush ,in denture wearers or in association with chronic hyperplastic candidosis. It is a characteristic sign of candidal infection.
  • 70. :Treatment of Oral Candidiasis Treatment of underlying predisposing factors (if possible) Antifungal Drugs     Antifungal antibiotics nystatin and amphotericin B. Imidazole derivatives (clotrimazole, miconazole) are available for topical use (cream, oral gel). Systemic therapy includes the use of any one of these three: ketoconazole, itraconazole, and fluconazole. Fluconazole and amphotericin B may be used intravenously for the treatment of the resistant lesions of CMC and systemic candidiasis.
  • 71.  Patients for whom predisposing factors such as xerostomia and immunodeficiency cannot be eliminated may need either continuous or repeated treatment to prevent recurrences.  The consumption of yogurt two to three times per week and improved oral hygiene can also help.
  • 72. :Idiopathic “TRUE” Leukoplakia  Leukoplakia is a white oral precancerous lesion with a recognizable risk for malignant transformation.  Leukoplakia is currently defined as “a white patch or plaque that cannot be characterized clinically or pathologically as any other disease”.
  • 73. Etiology  A number of locally acting etiologic agents, including tobacco, alcohol, candidiasis, electrogalvanic reactions, sunlight and (possibly) herpes simplex and papilloma viruses, have been implicated as causative factors for leukoplakia.  Alcohol consumption alone is not associated with an increased risk of developing leukoplakia, but alcohol is thought to serve as a promoter that exhibits a strong synergistic effect with tobacco.
  • 74. :Clinical Features More frequently found in men Can occur on any mucosal surface Infrequently causes discomfort or pain. Causes change in physical characteristics of tissues.  Prevalence increases rapidly with age.  Approximately 70% of oral leukoplakia lesions are found on the buccal mucosa, vermilion border of the lower lip, and gingiva.  Lesions of the tongue and the floor of the mouth account for more than 90% of cases that show dysplasia or carcinoma.    
  • 75. Subtypes  Homogeneous leukoplakia welldefined white patch, that is slightly elevated and that has a fissured, wrinkled, or corrugated surface. On palpation, these lesions may feel leathery to “dry, or cracked mud-like”.
  • 76.  Nodular (speckled) leukoplakia the name refers to a mixed red-and– white lesion in which keratotic white nodules or patches are distributed over an atrophic erythematous background. This type of leukoplakia is associated with a higher malignant transformation rate.
  • 78. Verrucous leukoplakia  Thick white lesions with papillary surfaces .  Usually heavily keratinized  Most often seen in older adults in the sixth to eighth decades of life.  Some of these lesions may exhibit an exophytic growth pattern.
  • 79. Proliferative verrucous leukoplakia Extensive papillary or verrucoid white plaques that tend to slowly involve multiple mucosal sites in the oral cavity and to transform into squamous cell carcinomas over a period of many years.
  • 80. :Histopathologic Features  Parakeratosis or orthokeratosis or both, alternately.  The epithelium ranges from thinner than normal (atrophic) to much thicker (acanthotic)  Most leukoplakias show no dysplastic changes  A minority display a range of dysplasia from mild to severe and treatment is planned partly on this basis.  An inflammatory reaction of lymphocytes and plasma cells is often present in the underlying connective tissue.
  • 81. :Diagnosis and Management  If a leukoplakia lesion disappears spontaneously or through the elimination of an irritant, no further testing is indicated.  For the persistent lesion, the definitive diagnosis is established by tissue biopsy.  Adjunctive methods as vital staining with toluidine blue and cytobrush are helpful in selecting the most appropriate spot for biopsy .
  • 82.  Toluidine blue staining uses a 1% aqueous solution of the dye which stains dysplastic and malignant cells and resists washing away by rinsing with 1% acetic acid .  Cytobrush technique utilizes a brush with firm bristles that obtains individual cells from the full thickness of epithelium for cytologic examination .
  • 83.  Definitive treatment involves surgical excision although cryosurgery and laser ablation are often preferred because of their precision and rapid healing.
  • 84. :Prognosis  Clinical signs of malignant transformation of leukoplakia include : Ulceration , erythroplasia , bleeding , induration and lymphadenopathy  After surgical removal long-term monitoring of the lesion site is important since recurrences are frequent and because additional leukoplakias may develop.
  • 85. Erythroplakia  “Bright red velvety plaque or patch which cannot be characterized clinically or histopathologically as being due to any other condition”.
  • 87. :Clinical Features  Erythroplakia occurs predominantly in older men, in the sixth and seventh decades of life.  Erythroplakias are more commonly seen on the floor of the mouth, the ventral tongue, the soft palate, and the tonsillar fauces, all prime areas for the development of carcinoma. Multiple lesions may be present.  Almost all of the lesions are asymptomatic.
  • 88. :Histopathologic Features  80 to 90% of cases of erythroplakia are histopathologically severe epithelial dysplasia, carcinoma in situ, or invasive carcinoma.
  • 89. :Differential Diagnosis  In view of the clinical significance of erythroplakia, its differentiation from other red inflammatory lesions of the oral mucosa is critical.  Clinically similar lesions may include erythematous candidiasis, areas of mechanical irritation, denture stomatitis, vascular lesions, and a variety of nonspecific inflammatory lesions
  • 90. :Lichen Planus  Lichen planus is a common chronic inflammatory disease of skin and mucous membranes. It mainly affects patients of middle age or over. Oral lesions have characteristic appearances and distribution
  • 91. :Aetiology  The predominantly T-lymphocyte infiltrate suggests cell-mediated immunological damage to the epithelium
  • 92. :Clinical Features Skin Lesions:  Pruritic, polyangular, planar papules and plaques , 2 to 4 mm in diameter, with angular borders, a violaceous color, and a distinct sheen in cross-lighting.  Usually symmetrically distributed most commonly on the flexor surfaces of the wrists, legs, trunk. The face is rarely involved during the acute phase.  New papules may appear at sites of minor skin injury (Koebner’s phenomenon).  Lesions may coalesce or change over time becoming hyperpigmented, atrophic hyperkeratotic (hypertrophic LP) or vesiculobullous.  If the scalp is affected,there is patchy scarring alopecia
  • 95. Nail Lesions:  Nails are involved in up to 10% of cases. Findings vary in intensity with nail bed discoloration ,longitudinal ridging and lateral thinning and complete loss of the nail matrix and nail with scarring of the proximal nail fold onto the nail bed.
  • 97. :Oral Lesions     The reticular form Atrophic lichen planus Erosive lesions Bullous lesions  Atrophic or erosive lichen planus involving the gingivae results in desquamative gingivitis
  • 100. :Histopathologic Features  Three features are considered essential for the histopathologic diagnosis of lichen planus:  (1) Areas of hyperparakeratosis or hyperorthokeratosis.  (2) “liquefaction degeneration” or necrosis of the basal cell layer which is often replaced by an eosinophilic band.  (3) A dense subepithelial band of lymphocytes. This linear sub-basilar lymphocytic infiltration is composed largely of T cells
  • 102.  Isolated epithelial cells, shrunken with eosinophilic cytoplasm and one or more pyknotic nuclear fragments (Civatte bodies), are often scattered within the epithelium and superficial lamina propria. These represent cells that have undergone apoptosis.
  • 103. :Treatment  Asymptomatic lesions require no treatment.  Topical high-potency corticosteroids, as pastes or as gels.  Erosive lesions may respond to oral dapsone or cyclosporine rinses.  Systemic steroids : Prednisone tablets with dosages varying between 40 and 80 mg daily  Intralesional injection of corticosteroid may be used in lesions resistant to topical and systemic therapy triamcinolone acetonide ampules are used (weekly regimen).  Systemically administered dapsone, hydroxychloroquine, azathioprine and cyclosporine may help in cases resistant to corticosteroids  Drug combinations could also be used.
  • 104. Lichenoid Reactions  This term is given to lichen planus-like lesions caused by either systemic drug treatment or those where the histological picture is not completely diagnostic.  Oral lichenoid reactions are most frequently responses to restorative materials, either amalgam or polymeric. Lesions are localized to mucosa in contact, not just close to, restorations.  Lichenoid reactions are treated in exactly the same way as lichen planus with withdrawal of drug(s) if possible or removal of restoration.
  • 105. :Lupus Erythematosus  Lupus erythematosus is an autoimmune connective tissue disease which has two main forms namely systemic and discoid. Either can give rise to oral lesions which may appear similar to those of oral lichen planus
  • 106. Systemic Lupus Erythematosus  Has varied effects. Any organ system can be affected. A great variety of autoantibodies, particularly antinuclear, is produced. Pathological features of systemic lupus erythematosus: Macroscopic:  Pleurisy.  Pericarditis.  Libman-sacks endocarditis.  Lymphadenopathy.  Splenomegaly.  May be none.
  • 108. Microscopic:  Immunoglobulins and complement at the dermo-epidermal junction in skin lesions (90%) and uninvolved skin (60%).  Haematoxylin bodies in the endocardium, renal glomeruli and elsewhere.  Periarterial fibrosis of the spleen.  Wire loop lesions in the kidneys.
  • 109. immunoglobulin & complement deposits at basement membrane :zone & nuclei of epithelial cells
  • 110. :Discoid Lupus  A skin disease with mucocutaneous lesions indistinguishable clinically from those of systemic lupus. These may be associated with arthralgias but rarely, significant autoantibody production
  • 111. Clinical Features: :A) Skin Lesions Cutaneous features of systemic lupus erythematosus.  Butterfly rash.  Facial oedema.  Subacute cutaneous LE.  Chronic discoid LE.  Scarring DLE alopecia  Non-scarring alopecia  Photosensitivity  Raynaud’s phenomenon  Chronic urticaria  Cutaneous vasculitis
  • 116. :Histopathologic Features  Liquefaction degeneration of basal cell layer.  Degenerative changes in the connective tissue (hyalinization, oedema,..).  Lupus erythematosus shows more irregular patterns of acanthosis and lacks the band-like distribution of lymphocytes in the papillary corium of lichen planus.  The inflammatory infiltrate may have a perivascular distribution.
  • 117. : Management  Oral lesions of discoid lupus erythematosus may respond in some degree to topical corticosteroids.  Oral lesions in acute systemic lupus erythematosus may not respond to doses of corticosteroids adequate to control systemic effects of the disease. Under such circumstances, palliative treatment is needed until disease activity decreases.
  • 118. Miscellaneous Lesions: Oral Submucous Fibrosis  A slowly progressive chronic fibrotic disease of the oral cavity and oropharynx, characterized by fibroelastic change and inflammation of the mucosa, leading to a progressive inability to open the mouth, swallow, or speak.
  • 119.  These reactions may be the result of either direct stimulation from exogenous antigens like Areca alkaloids or changes in tissue antigenicity that may lead to an autoimmune response.  It occurs almost exclusively in the Indian subcontinent.  The inflammatory response releases cytokines and growth factorsthat promote fibrosis by inducing the proliferation of fibroblasts, up-regulating collagen synthesis and down-regulating collagenase production.
  • 120. :Etiology  General nutritional and vitamin deficiencies and hypersensitivity to certain dietary constituents such as chili peppers, chewing tobacco, habitual use of betel and its constituents (Areca catechu).
  • 121. :Clinical Features  The disease first presents with a burning sensation of the mouth, particularly during consumption of spicy foods.  Often accompanied by the formation of vesicles or ulcerations and by excessive salivation or xerostomia and altered taste sensations.  Gradually, patients develop a stiffening of the mucosa, with a dramatic reduction in mouth opening and with difficulty in swallowing and speaking.  The mucosa appears blanched and opaque with the appearance of fibrotic bands that can easily be palpated.  Usually involves the buccal mucosa, soft palate, posterior pharynx, lips, and tongue.
  • 124. :Histologic Features  Severely atrophic epithelium with complete loss of rete ridges.  Varying degrees of epithelial atypia may be present.  The underlying lamina propria exhibits severe hyalinization, with homogenization of collagen. Cellular elements and blood vessels are greatly reduced.
  • 125. :Treatment and Prognosis  Oral submucous fibrosis is regarded as a premalignant condition.  Oral submucous fibrosis is very resistant to treatment.  Submucosal injected steroids and hyaluronidase, are some of the agents that have been used.  In severe cases surgical intervention is the only treatment but the fibrous bands and other symptoms often recur within a few months to a few years.
  • 126. :Skin Grafts  A skin graft may be placed in the mouth to cover a raw area left after excision of a lesion.  Skin grafts typically appear sharply demarcated smooth and paler than the surrounding mucosa and occasionally contain hairs . Grafts on the dorsum of the tongue may become corrugated and less easy to differentiate from leukoplakia.